x_label	specimen_descriptor_fill	box_sample_count	Gene_Ensembl_ID	Gene_symbol	PMTL	Dataset	Disease	GTEx_tissue_subgroup	EFO	MONDO	GTEx_tissue_subgroup_UBERON	TPM_mean	TPM_sd	TPM_min	TPM_25th_percentile	TPM_median	TPM_75th_percentile	TPM_max
Osteosarcoma  (Dataset = TARGET, Specimen = Pediatric Primary Tumors, N = 87)	Pediatric Primary Tumors	87	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TARGET	Osteosarcoma		EFO_0000637	MONDO_0009807		3.11	3.86	0.45	1.47	2.15	3.43	32.2
Acute Myeloid Leukemia  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 147)	TCGA Primary Tumors	147	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Acute Myeloid Leukemia		EFO_0000222	MONDO_0018874		15.44	8.05	1.64	9.92	14.82	19.06	55.63
Adrenocortical Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 77)	TCGA Primary Tumors	77	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Adrenocortical Carcinoma		EFO_1000796	MONDO_0006639		0.96	1.03	0.02	0.28	0.51	1.44	5.41
Bladder Urothelial Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 405)	TCGA Primary Tumors	405	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Bladder Urothelial Carcinoma		EFO_0006544	MONDO_0005611		3.76	3.83	0.24	1.67	2.89	4.78	38.26
Breast Invasive Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 1088)	TCGA Primary Tumors	1088	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Breast Invasive Carcinoma		EFO_1000307	MONDO_0006256		3.63	2.9	0.06	1.67	2.81	4.73	23.46
Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 304)	TCGA Primary Tumors	304	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma		EFO_1000162	MONDO_0006143		5.16	2.93	0.46	3.06	4.66	6.54	22.32
Cholangiocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 35)	TCGA Primary Tumors	35	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Cholangiocarcinoma		EFO_0005221	MONDO_0019087		1.56	0.89	0.21	0.88	1.32	2.07	3.49
Chromophobe renal cell carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 65)	TCGA Primary Tumors	65	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Chromophobe renal cell carcinoma		EFO_0000335	MONDO_0017885		0.31	0.45	0.02	0.11	0.18	0.28	2.56
Colon Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 288)	TCGA Primary Tumors	288	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Colon Adenocarcinoma		EFO_1001949	MONDO_0002271		5.41	5.97	0.69	2.94	4.34	6.43	77.56
Cutaneous Melanoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 102)	TCGA Primary Tumors	102	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Cutaneous Melanoma		EFO_0000389	MONDO_0005012		2.25	2.09	0.04	0.72	1.66	3.34	13.44
Esophageal Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 158)	TCGA Primary Tumors	158	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Esophageal Carcinoma		EFO_0002916	MONDO_0019086		7.57	5.34	0.27	3.94	6.16	9.26	31.38
Glioblastoma Multiforme  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 152)	TCGA Primary Tumors	152	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Glioblastoma Multiforme		EFO_0000519	MONDO_0018177		1.81	1.37	0.19	0.97	1.52	2.17	9.49
Head and Neck Squamous Cell Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 498)	TCGA Primary Tumors	498	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Head and Neck Squamous Cell Carcinoma		EFO_0000181	MONDO_0010150		3.58	2.82	0.1	1.73	2.91	4.49	24.82
Hepatocellular Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 369)	TCGA Primary Tumors	369	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Hepatocellular Carcinoma		EFO_0000182	MONDO_0007256		0.82	0.84	0.04	0.28	0.52	0.99	5.44
Low-grade glioma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 507)	TCGA Primary Tumors	507	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Low-grade glioma		MONDO_0021637	MONDO_0021637		1.03	1.34	0.07	0.35	0.57	1.08	11.25
Lung Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 510)	TCGA Primary Tumors	510	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Lung Adenocarcinoma		EFO_0000571	MONDO_0005061		2.33	2.05	0.2	1.19	1.75	2.76	25.25
Lung Squamous Cell Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 498)	TCGA Primary Tumors	498	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Lung Squamous Cell Carcinoma		EFO_0000708	MONDO_0005097		3.45	2.1	0.23	1.96	3.1	4.28	13.91
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 47)	TCGA Primary Tumors	47	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Lymphoid Neoplasm Diffuse Large B-cell Lymphoma		EFO_0000403	MONDO_0018905		4.37	3.01	0.42	2.21	3.27	5.94	12.01
Mesothelioma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 86)	TCGA Primary Tumors	86	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Mesothelioma		EFO_0000588	MONDO_0005065		2.04	1.19	0.35	1.36	1.88	2.47	7.21
Ovarian Serous Cystadenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 373)	TCGA Primary Tumors	373	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Ovarian Serous Cystadenocarcinoma		EFO_1000043	MONDO_0006046		1.98	1.37	0.23	1.06	1.63	2.49	11.78
Pancreatic Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 177)	TCGA Primary Tumors	177	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Pancreatic Adenocarcinoma		EFO_1000044	MONDO_0006047		1.51	0.84	0.1	0.95	1.32	1.96	4.54
Pheochromocytoma and Paraganglioma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 177)	TCGA Primary Tumors	177	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Pheochromocytoma and Paraganglioma		EFO_0020005	MONDO_0035540		0.39	0.28	0.05	0.19	0.3	0.52	2.01
Prostate Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 494)	TCGA Primary Tumors	494	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Prostate Adenocarcinoma		EFO_0000673	MONDO_0005082		0.52	0.51	0.03	0.25	0.4	0.61	4.87
Rectum Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 92)	TCGA Primary Tumors	92	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Rectum Adenocarcinoma		EFO_0005631	MONDO_0002169		5.44	2.84	0.98	3.18	4.67	7.55	13.95
Renal Clear Cell Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 527)	TCGA Primary Tumors	527	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Renal Clear Cell Carcinoma		EFO_0000349	MONDO_0005005		1.36	1.01	0.01	0.74	1.18	1.74	10.35
Renal Papillary Cell Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 286)	TCGA Primary Tumors	286	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Renal Papillary Cell Carcinoma		EFO_0000640	MONDO_0017884		0.63	0.64	0.02	0.25	0.46	0.82	5.68
Sarcoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 258)	TCGA Primary Tumors	258	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Sarcoma		EFO_0000691	MONDO_0005089		3.52	3.04	0.05	1.57	2.5	4.62	18.43
Stomach Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 373)	TCGA Primary Tumors	373	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Stomach Adenocarcinoma		EFO_0000503	MONDO_0005036		5.5	7.07	0.28	2.63	4.35	6.72	122.73
Testicular Germ Cell Tumor  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 148)	TCGA Primary Tumors	148	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Testicular Germ Cell Tumor		EFO_1000566	MONDO_0010108		4.4	2.39	0.42	2.68	3.9	5.71	11.11
Thymoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 118)	TCGA Primary Tumors	118	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Thymoma		EFO_1000581	MONDO_0006456		3.47	2.1	0.46	1.78	3.17	4.92	12.43
Thyroid Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 501)	TCGA Primary Tumors	501	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Thyroid Carcinoma		EFO_0002892	MONDO_0015075		0.76	0.39	0.08	0.45	0.7	1.02	2.59
Uterine Carcinosarcoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 56)	TCGA Primary Tumors	56	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Uterine Carcinosarcoma		EFO_1000613	MONDO_0006485		3.12	1.36	1.01	2.06	2.95	4.04	5.85
Uterine Corpus Endometrial Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 178)	TCGA Primary Tumors	178	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Uterine Corpus Endometrial Carcinoma		EFO_0007532	MONDO_0000553		3.06	3.35	0.04	1.42	2.28	3.68	26.79
Uveal Melanoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 79)	TCGA Primary Tumors	79	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Uveal Melanoma		EFO_1000616	MONDO_0006486		0.38	0.36	0	0.11	0.25	0.6	1.54
